Ramy Arnaout, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Nasopharynx | 5 | 2022 | 420 | 1.630 |
Why?
|
| Clinical Laboratory Techniques | 5 | 2022 | 749 | 1.490 |
Why?
|
| Specimen Handling | 5 | 2024 | 708 | 1.360 |
Why?
|
| Adaptive Immunity | 2 | 2022 | 731 | 1.080 |
Why?
|
| Sarcina | 1 | 2023 | 10 | 0.900 |
Why?
|
| Receptors, Antigen, T-Cell | 2 | 2022 | 2568 | 0.810 |
Why?
|
| Immunoglobulin Heavy Chains | 2 | 2014 | 648 | 0.690 |
Why?
|
| Hematologic Tests | 1 | 2021 | 239 | 0.680 |
Why?
|
| Diagnostic Tests, Routine | 3 | 2021 | 790 | 0.660 |
Why?
|
| Viral Load | 6 | 2024 | 3398 | 0.650 |
Why?
|
| Stomach | 1 | 2023 | 703 | 0.650 |
Why?
|
| Saliva | 1 | 2021 | 854 | 0.540 |
Why?
|
| Complementarity Determining Regions | 2 | 2014 | 150 | 0.530 |
Why?
|
| Epitopes | 1 | 2022 | 2525 | 0.510 |
Why?
|
| Limit of Detection | 4 | 2022 | 276 | 0.450 |
Why?
|
| Models, Economic | 2 | 2013 | 718 | 0.450 |
Why?
|
| Equipment Design | 1 | 2020 | 3529 | 0.400 |
Why?
|
| Chemistry, Clinical | 1 | 2012 | 64 | 0.390 |
Why?
|
| Pharmacogenetics | 2 | 2013 | 683 | 0.390 |
Why?
|
| B-Lymphocytes | 2 | 2016 | 4785 | 0.390 |
Why?
|
| Pathology, Clinical | 2 | 2011 | 376 | 0.350 |
Why?
|
| High-Throughput Nucleotide Sequencing | 3 | 2021 | 3666 | 0.350 |
Why?
|
| Laboratories, Hospital | 1 | 2011 | 192 | 0.340 |
Why?
|
| Computers | 1 | 2012 | 592 | 0.330 |
Why?
|
| Early Diagnosis | 1 | 2014 | 1195 | 0.320 |
Why?
|
| Head | 1 | 2014 | 927 | 0.300 |
Why?
|
| Statistics as Topic | 1 | 2014 | 2363 | 0.290 |
Why?
|
| Diagnostic Errors | 1 | 2013 | 1280 | 0.260 |
Why?
|
| Medical Records Systems, Computerized | 1 | 2012 | 1196 | 0.260 |
Why?
|
| Sensitivity and Specificity | 6 | 2024 | 14737 | 0.250 |
Why?
|
| RNA, Viral | 3 | 2021 | 2866 | 0.220 |
Why?
|
| Clostridium | 1 | 2023 | 101 | 0.220 |
Why?
|
| Freezing | 1 | 2024 | 311 | 0.210 |
Why?
|
| Decision Support Systems, Clinical | 1 | 2012 | 1177 | 0.210 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 3118 | 0.200 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 3241 | 0.200 |
Why?
|
| Polymerase Chain Reaction | 4 | 2023 | 6085 | 0.200 |
Why?
|
| Inpatients | 1 | 2014 | 2570 | 0.200 |
Why?
|
| Delirium | 1 | 2014 | 1695 | 0.200 |
Why?
|
| Mycobacterium | 1 | 2023 | 252 | 0.200 |
Why?
|
| Genomics | 3 | 2013 | 5916 | 0.190 |
Why?
|
| Fungi | 1 | 2023 | 345 | 0.180 |
Why?
|
| Evidence-Based Medicine | 1 | 2013 | 3707 | 0.180 |
Why?
|
| Electronic Health Records | 2 | 2015 | 4875 | 0.170 |
Why?
|
| Time | 1 | 2021 | 546 | 0.170 |
Why?
|
| Health Care Costs | 1 | 2013 | 3267 | 0.160 |
Why?
|
| Pancreatitis, Chronic | 1 | 2022 | 282 | 0.160 |
Why?
|
| Internet | 1 | 2011 | 3107 | 0.160 |
Why?
|
| Vertebrates | 1 | 2000 | 227 | 0.160 |
Why?
|
| Humans | 36 | 2024 | 768393 | 0.160 |
Why?
|
| Models, Immunological | 2 | 2000 | 518 | 0.160 |
Why?
|
| T-Lymphocytes | 1 | 2016 | 10267 | 0.150 |
Why?
|
| Predictive Value of Tests | 2 | 2014 | 15455 | 0.150 |
Why?
|
| HIV-1 | 5 | 2009 | 6963 | 0.150 |
Why?
|
| Brain Mapping | 1 | 2013 | 6740 | 0.150 |
Why?
|
| Artificial Intelligence | 1 | 2012 | 2661 | 0.140 |
Why?
|
| Islets of Langerhans Transplantation | 1 | 2022 | 748 | 0.140 |
Why?
|
| Pandemics | 3 | 2022 | 8753 | 0.140 |
Why?
|
| Respiratory Syncytial Virus Infections | 1 | 2021 | 365 | 0.140 |
Why?
|
| Molecular Diagnostic Techniques | 1 | 2021 | 620 | 0.130 |
Why?
|
| South Africa | 1 | 2022 | 1871 | 0.130 |
Why?
|
| Immunity | 1 | 2022 | 1003 | 0.130 |
Why?
|
| T-Lymphocytes, Cytotoxic | 2 | 2000 | 1795 | 0.130 |
Why?
|
| Ventral Tegmental Area | 1 | 2017 | 136 | 0.130 |
Why?
|
| Mediastinal Diseases | 1 | 2015 | 91 | 0.120 |
Why?
|
| Benchmarking | 1 | 2021 | 1058 | 0.120 |
Why?
|
| Virus Diseases | 1 | 2000 | 723 | 0.110 |
Why?
|
| Internship and Residency | 2 | 2011 | 5949 | 0.110 |
Why?
|
| Lymphatic Diseases | 1 | 2015 | 319 | 0.110 |
Why?
|
| Ceruloplasmin | 1 | 2013 | 57 | 0.110 |
Why?
|
| Hepatolenticular Degeneration | 1 | 2013 | 73 | 0.110 |
Why?
|
| Protein Precursors | 1 | 2017 | 1134 | 0.100 |
Why?
|
| Reference Standards | 1 | 2016 | 1013 | 0.100 |
Why?
|
| Liver Function Tests | 1 | 2013 | 526 | 0.100 |
Why?
|
| Aged, 80 and over | 4 | 2023 | 59686 | 0.090 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 1999 | 2202 | 0.090 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2014 | 20765 | 0.090 |
Why?
|
| Social Behavior | 1 | 2017 | 1146 | 0.090 |
Why?
|
| Peptides | 1 | 2022 | 4353 | 0.090 |
Why?
|
| Influenza, Human | 1 | 2021 | 1539 | 0.090 |
Why?
|
| Software | 1 | 2024 | 4453 | 0.090 |
Why?
|
| Down-Regulation | 1 | 2017 | 2940 | 0.080 |
Why?
|
| Adverse Drug Reaction Reporting Systems | 1 | 2013 | 495 | 0.080 |
Why?
|
| DNA Primers | 2 | 2011 | 2825 | 0.080 |
Why?
|
| Diagnostic Imaging | 1 | 2023 | 3541 | 0.080 |
Why?
|
| Awards and Prizes | 1 | 2013 | 365 | 0.080 |
Why?
|
| Reproducibility of Results | 3 | 2016 | 20224 | 0.070 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2017 | 1901 | 0.070 |
Why?
|
| Autistic Disorder | 1 | 2017 | 1240 | 0.070 |
Why?
|
| Communicable Diseases | 1 | 2015 | 873 | 0.070 |
Why?
|
| Hospitals | 1 | 2020 | 3906 | 0.070 |
Why?
|
| Delivery of Health Care, Integrated | 1 | 2015 | 954 | 0.070 |
Why?
|
| Simian Acquired Immunodeficiency Syndrome | 2 | 2000 | 545 | 0.060 |
Why?
|
| Base Sequence | 3 | 2011 | 12422 | 0.060 |
Why?
|
| Simian immunodeficiency virus | 2 | 2000 | 814 | 0.060 |
Why?
|
| Liver Diseases | 1 | 2013 | 1304 | 0.060 |
Why?
|
| Regression Analysis | 1 | 2014 | 6350 | 0.060 |
Why?
|
| Virus Cultivation | 1 | 2024 | 88 | 0.060 |
Why?
|
| Immunity, Cellular | 2 | 2000 | 1561 | 0.060 |
Why?
|
| Nerve Tissue Proteins | 1 | 2017 | 4414 | 0.060 |
Why?
|
| Lymph Nodes | 1 | 2015 | 3471 | 0.060 |
Why?
|
| Linear Models | 1 | 2014 | 5878 | 0.060 |
Why?
|
| Seizures | 1 | 2017 | 3000 | 0.060 |
Why?
|
| Genetic Techniques | 1 | 2006 | 428 | 0.050 |
Why?
|
| Female | 10 | 2023 | 397089 | 0.050 |
Why?
|
| HIV Infections | 4 | 2009 | 17575 | 0.050 |
Why?
|
| Guideline Adherence | 1 | 2013 | 2240 | 0.050 |
Why?
|
| Microbial Viability | 1 | 2024 | 235 | 0.050 |
Why?
|
| Computer Simulation | 1 | 2016 | 6277 | 0.050 |
Why?
|
| Influenza B virus | 1 | 2021 | 53 | 0.050 |
Why?
|
| Immunologic Tests | 1 | 2022 | 104 | 0.050 |
Why?
|
| Massachusetts | 1 | 2014 | 8902 | 0.050 |
Why?
|
| Genetic Variation | 1 | 2016 | 6606 | 0.050 |
Why?
|
| Computational Biology | 1 | 2013 | 3543 | 0.040 |
Why?
|
| Sequence Analysis, DNA | 2 | 2009 | 4775 | 0.040 |
Why?
|
| Male | 10 | 2022 | 364902 | 0.040 |
Why?
|
| Serologic Tests | 1 | 2022 | 383 | 0.040 |
Why?
|
| Time Factors | 4 | 2014 | 40272 | 0.040 |
Why?
|
| Respiratory Syncytial Virus, Human | 1 | 2021 | 149 | 0.040 |
Why?
|
| Nucleic Acid Amplification Techniques | 1 | 2021 | 339 | 0.040 |
Why?
|
| Organophosphorus Compounds | 1 | 2000 | 207 | 0.040 |
Why?
|
| Cryopreservation | 1 | 2024 | 733 | 0.040 |
Why?
|
| Diagnosis, Differential | 1 | 2014 | 13020 | 0.040 |
Why?
|
| Piperazines | 1 | 2009 | 2552 | 0.040 |
Why?
|
| Influenza A virus | 1 | 2021 | 460 | 0.040 |
Why?
|
| Pancreatectomy | 1 | 2022 | 824 | 0.040 |
Why?
|
| Transplantation, Autologous | 1 | 2022 | 2127 | 0.030 |
Why?
|
| Pyrimidines | 1 | 2009 | 3048 | 0.030 |
Why?
|
| Reverse Transcriptase Inhibitors | 1 | 2000 | 622 | 0.030 |
Why?
|
| CD4 Lymphocyte Count | 2 | 2000 | 2596 | 0.030 |
Why?
|
| Middle Aged | 4 | 2021 | 223491 | 0.030 |
Why?
|
| Lung | 1 | 2015 | 10089 | 0.030 |
Why?
|
| Aged | 3 | 2020 | 171562 | 0.030 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2015 | 5422 | 0.030 |
Why?
|
| Young Adult | 2 | 2020 | 60049 | 0.030 |
Why?
|
| Antibody Formation | 1 | 2000 | 1393 | 0.030 |
Why?
|
| Algorithms | 1 | 2016 | 14154 | 0.030 |
Why?
|
| Retrospective Studies | 4 | 2023 | 81801 | 0.030 |
Why?
|
| Patient Identification Systems | 1 | 2015 | 75 | 0.030 |
Why?
|
| Chromatin | 1 | 2006 | 2968 | 0.030 |
Why?
|
| Adenine | 1 | 2000 | 993 | 0.030 |
Why?
|
| Tissue Banks | 1 | 2015 | 184 | 0.030 |
Why?
|
| Adult | 3 | 2020 | 223640 | 0.030 |
Why?
|
| Immunologic Memory | 1 | 2000 | 1374 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2014 | 39407 | 0.030 |
Why?
|
| Radiography | 1 | 2023 | 6993 | 0.020 |
Why?
|
| Mice | 3 | 2017 | 82017 | 0.020 |
Why?
|
| Animals | 6 | 2017 | 169337 | 0.020 |
Why?
|
| Glutamic Acid | 1 | 2017 | 1193 | 0.020 |
Why?
|
| Synaptic Transmission | 1 | 2017 | 1175 | 0.020 |
Why?
|
| Lung Neoplasms | 1 | 2015 | 13576 | 0.020 |
Why?
|
| Mathematical Computing | 2 | 2000 | 142 | 0.020 |
Why?
|
| Demography | 1 | 2015 | 1642 | 0.020 |
Why?
|
| Entropy | 1 | 2009 | 211 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2006 | 11918 | 0.020 |
Why?
|
| Proteomics | 1 | 2022 | 3906 | 0.020 |
Why?
|
| Models, Theoretical | 1 | 2000 | 3579 | 0.020 |
Why?
|
| Cell Nucleus | 1 | 2017 | 2886 | 0.020 |
Why?
|
| Palliative Care | 1 | 2023 | 3643 | 0.020 |
Why?
|
| Antiviral Agents | 1 | 2000 | 3064 | 0.020 |
Why?
|
| Practice Guidelines as Topic | 2 | 2015 | 7453 | 0.020 |
Why?
|
| Chromosomes, Artificial, Bacterial | 1 | 2006 | 125 | 0.020 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2023 | 9063 | 0.020 |
Why?
|
| Likelihood Functions | 1 | 2009 | 993 | 0.020 |
Why?
|
| Globins | 1 | 2006 | 405 | 0.020 |
Why?
|
| Nucleic Acid Conformation | 1 | 2009 | 900 | 0.020 |
Why?
|
| United States | 1 | 2013 | 73150 | 0.010 |
Why?
|
| Sequence Alignment | 1 | 2009 | 2176 | 0.010 |
Why?
|
| Selection, Genetic | 1 | 2009 | 877 | 0.010 |
Why?
|
| Anti-HIV Agents | 1 | 2000 | 4571 | 0.010 |
Why?
|
| Evaluation Studies as Topic | 1 | 2006 | 1629 | 0.010 |
Why?
|
| Disease Management | 1 | 2015 | 2537 | 0.010 |
Why?
|
| Microarray Analysis | 1 | 2006 | 753 | 0.010 |
Why?
|
| Biological Evolution | 1 | 2009 | 1078 | 0.010 |
Why?
|
| Treatment Failure | 1 | 2009 | 2663 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2017 | 12805 | 0.010 |
Why?
|
| Lymphocytic Choriomeningitis | 1 | 2000 | 140 | 0.010 |
Why?
|
| Macaca | 1 | 2000 | 417 | 0.010 |
Why?
|
| Neurons | 1 | 2017 | 9513 | 0.010 |
Why?
|
| Curriculum | 1 | 2010 | 3776 | 0.010 |
Why?
|
| Age Factors | 1 | 2013 | 18471 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2022 | 65379 | 0.010 |
Why?
|
| Clinical Competence | 1 | 2010 | 4848 | 0.010 |
Why?
|
| Prognosis | 1 | 2015 | 30022 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2006 | 17626 | 0.010 |
Why?
|
| Macaca mulatta | 1 | 2000 | 2362 | 0.010 |
Why?
|
| Virus Replication | 1 | 2000 | 2458 | 0.010 |
Why?
|
| Acute Disease | 1 | 2000 | 7242 | 0.010 |
Why?
|
| Lymphocyte Activation | 1 | 2000 | 5496 | 0.010 |
Why?
|
| Models, Biological | 1 | 2000 | 9493 | 0.000 |
Why?
|